Filing metadata

Accession number
0000950170-25-022321
Form type
Form 4
Filer
Neumora Therapeutics, Inc.
CIK
CIK 1885522
Filed
Feb 18, 2025
Reporting period
Feb 13, 2025
Description
Insider transaction

Explore SEC Filings Hub